Crowdonomics
WatchlistPortfolio
HERBAL BOTANICAL PRODUCTS, LLC

Reg CF · Preferred Stock · May 2023

ClosedReached targetReg CFPreferred Equity
via WeFunderView campaign
Raised
$52.5K / $124K max
42% of ceiling · target hit day 5
Investors
15
$3.5K avg
Post-money valuation
$12.6M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$73K$36K$0
1790
May 15, 2023 · openedSep 1, 2023 · last reading
Target ($50K) hit — May 20, 2023, day 5Deadline Apr 29, 2024 — 241 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2021–FY2022 · hover for source
$20K
−$189K
FY2021
$16K
−$240K
FY2022
RevenueNet income
Metric
FY2021 unaudited
FY2022 unaudited
Income statement
Revenue
$20,196
$16,000
Cost of goods sold
$5,426
$5,758
Gross margin
73%
64%
Net income
-$188,904
-$239,509
Taxes paid
$0
$0
Balance sheet
Cash
$67,003
$34,264
Accounts receivable
$0
$0
Total assets
$283,611
$316,301
Short-term debt
$68,183
$74,265
Long-term debt
$0
$0
Total liabilities
$68,183
$74,265
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$12.5M
Post-money$12.6M
Price / share$100.00
Shares offered500

Offering details

Target$50,000
Max$124,000
Min investment$100
OpenedMay 15, 2023
DeadlineApr 29, 2024
ClosedSep 2, 2023
Days active110

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-23-000544

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.